Planning to Conceive? Your Genes May Be Sabotaging Your Fertility.

The MTHFR gene encodes an enzyme that converts folate from your diet into methylfolate, the active form your cells use to carry methyl groups throughout your body. This methylation process is essential for DNA synthesis, DNA repair, and the epigenetic marking of genes that governs how cells behave. In fertility, methylation is critical for proper embryo development and neural tube closure in your future baby. Your eggs and your partner’s sperm both depend on intact methylation.

The most common variant is MTHFR C677T, carried by roughly 40% of people with European ancestry. If you carry one copy, your MTHFR enzyme works at about 65% efficiency; two copies drop it to 35% efficiency. Even with a diet rich in leafy greens and supplemental folic acid, your cells may be chronically short of the methylfolate they need for optimal egg development and DNA protection in sperm. Standard bloodwork won’t reveal this. Your folate level may look normal because serum folate measures what’s circulating, not what your cells can actually use.

This manifests as difficulty conceiving, recurrent miscarriage, or delayed embryo development. If your MTHFR is impaired, your eggs may have poor spindle formation during division, increasing chromosome missegregation and miscarriage risk. Your partner’s sperm DNA may be inadequately methylated, reducing protection from oxidative damage. Even if you do conceive, impaired methylation increases neural tube defect risk.

The VDR gene encodes the vitamin D receptor, a protein in your cell nucleus that binds activated vitamin D and acts as a switch for hundreds of genes involved in calcium absorption, immune regulation, and mitochondrial energy production. In preconception, vitamin D receptor function is critical for immune tolerance (so your body doesn’t reject the embryo), for calcium homeostasis (essential for egg meiosis and mitochondrial function), and for metabolic health.

The FokI variant is the most functional. Roughly 30-50% of the population carries variants that reduce VDR sensitivity. You can take 4,000 IU of vitamin D daily and still have a functionally vitamin D deficient state at the cellular level, because your cells can’t respond to the vitamin D that’s there. Your serum 25-hydroxyvitamin D level may reach 40 ng/mL, which standard medicine considers adequate, but your tissues are not receiving the signal. This is especially problematic for women planning pregnancy; vitamin D deficiency is associated with lower ovarian reserve, poorer egg quality, and higher miscarriage rates.

Symptomatically, this appears as recurrent infections or slow recovery from illness (immune dysregulation), difficulty absorbing calcium despite adequate intake, delayed ovulation, or metabolic sluggishness. Your mitochondria aren’t responding adequately to vitamin D’s signaling, so cellular energy production is suboptimal.

The COMT gene encodes an enzyme that breaks down catecholamines (dopamine, norepinephrine, epinephrine) and also conjugates estrogen for clearance through your liver. Efficient estrogen clearance is foundational to fertility because elevated estrogen is associated with endometriosis, PCOS, and poor ovarian response to stimulation during IVF. Your COMT variant determines how quickly you metabolize and clear estrogen.

The Val158Met variant is common, and the Met/Met (slow COMT) genotype occurs in roughly 25% of people with European ancestry. Slow COMT means estrogen is cleared more slowly, so it circulates longer and exerts more effect on endometrial tissue. Slow COMT combined with inflammatory diet or high stress creates a perfect storm for elevated estrogen and endometrial inflammation, which directly impairs implantation and increases miscarriage risk. This is especially relevant if you have endometriosis, heavy periods, or a history of poor implantation.

You may experience heavy or prolonged periods, estrogen dominance symptoms (water retention, mood changes before ovulation), or endometriosis pain. If pursuing IVF, slow COMT is associated with overresponse to FSH stimulation, requiring more careful protocol monitoring.

The FSHR gene encodes the follicle-stimulating hormone receptor, located on the surface of granulosa cells in ovarian follicles. FSH binds to this receptor to stimulate follicle growth, estrogen production, and ultimately ovulation. Your FSHR variant determines how sensitive your ovaries are to FSH signaling. This directly affects how many eggs recruit and develop each cycle, and it’s critical if you’re considering IVF.

The N680S variant (rs6166) occurs in roughly 10-15% of the population, and the S/S genotype is associated with reduced FSH receptor sensitivity. If you have the S/S variant, your ovaries respond more sluggishly to FSH, meaning fewer follicles recruit, you may have lower ovarian reserve, and during IVF stimulation you may require higher doses of FSH to generate an adequate response. This doesn’t mean you can’t conceive naturally or through IVF; it means your protocol needs adjustment. Standard FSH doses won’t generate the same response as in women with N/N or N/S genotypes.

This manifests as lower antral follicle counts, higher day-3 FSH levels, or poor ovarian response to standard IVF stimulation. You may have conceived easily in your twenties but find conception harder in your thirties as natural ovarian reserve declines. If you pursue assisted reproduction, this variant predicts that you’ll need more aggressive stimulation protocols.

The HFE gene encodes a protein that helps regulate hepcidin, the master hormone of iron absorption. Your body has no biological mechanism to excrete excess iron, so iron must be tightly controlled at the absorption level. Too much iron generates dangerous reactive oxygen species that damage mitochondria and DNA. Too little iron impairs oxygen transport and energy production in eggs and sperm. The HFE variants C282Y and H63D alter how efficiently you absorb and retain iron.

The H63D variant occurs in roughly 15-20% of people with European ancestry and is associated with mild iron dysregulation; some carriers retain iron excessively, others absorb less efficiently. If you carry H63D, your iron levels may drift higher than optimal, which increases oxidative stress and impairs mitochondrial function in your eggs, reducing egg quality and viability. Alternatively, some H63D carriers have subtle iron absorption deficiency, which impairs oxygen transport and reduces energy production in developing eggs and sperm.

You may feel unexplained fatigue despite normal hemoglobin levels, or you may have high ferritin (iron overload). If overload, you may experience joint pain, metabolic slowness, or brain fog. High iron in eggs is associated with increased miscarriage risk due to oxidative damage to oocyte mitochondria.

The SOD2 gene encodes superoxide dismutase 2, an antioxidant enzyme that works inside your cell mitochondria to neutralize reactive oxygen species (ROS) produced during energy generation. Mitochondria are the powerhouse of your cells, and the health of your egg mitochondria directly determines egg quality, developmental potential, and implantation capacity. SOD2 is your first line of defense against oxidative stress in the mitochondrial compartment.

Common SOD2 variants alter the efficiency of this enzyme. Roughly 30-40% of the population carries a variant associated with reduced SOD2 activity. If your SOD2 is compromised, your egg mitochondria accumulate oxidative damage over time, which accelerates the age-related decline in egg quality and increases miscarriage risk due to chromosomal errors. This is especially critical if you’re over 35, planning to delay conception, or concerned about egg quality with advancing age.

You may notice oxidative stress symptoms like fatigue that worsens with exercise, poor recovery from physical exertion, or accelerated skin aging. If pursuing fertility treatment, poor egg quality despite normal AMH (anti-Müllerian hormone) and antral follicle counts may point to mitochondrial stress rather than quantity issues.